title: Influence of epoietinum therapy on the oxidative stress in haemodialysis patients.
abstract: BACKGROUND
  The causes of oxidative stress in haemodialysis (HD) patients are still controversial. Beside the uraemic state and dialysis-related factors, adjuvant drug therapies such as epoietinum (rHuEpo) and intravenous iron were involved.
  
  
  METHODS
  Several parameters related to oxidative stress were assessed by spectrophotometry in stable HD patients, treated for at least 2 months with epoietinum (n = 14; mean dose = 97.7 +/- 19.1 U/kg/week) or not (n = 15), none of them on iron therapy, and in 13 controls. Plasma thiobarbituric acid-reactive substances (TBARS) were used as markers of reactive species generation. Erythrocyte and plasma antioxidant systems, reflected by non-protein erythrocyte thiols, and erythrocyte enzyme activities -- superoxide dismutase (SOD), glutathione peroxidase, catalase and plasma total thiols, respectively -- were also investigated.
  
  
  RESULTS
  There were no differences between HD subgroups regarding haemoglobin levels. Plasma TBARS was increased in all HD patients as opposed to controls, irrespective of rHuEpo therapy. In addition, no change in antioxidant status parameters between rHuEpo-treated and -untreated patients was observed. Except for SOD, the other antioxidant indices were higher in all HD patients versus controls.
  
  
  CONCLUSIONS
  These results suggest that (1) chronic HD patients appear to have simultaneously enhanced reactive species generation and antioxidative systems efficiency, and (2) epoietinum therapy did not change their oxidative status, at least in the absence of concomitant iron supplementation and at similar haemoglobin levels.
authors.affiliation: Dr Carol Davila Teaching Hospital of Nephrology, Bucharest, Romania. cdavilla@dsnet.ro
authors.forename: Gabriel
authors.initials: G
authors.lastname: Mircescu
authors.forename: Cristina
authors.initials: C
authors.lastname: Căpuşă
authors.forename: Irina
authors.initials: I
authors.lastname: Stoian
authors.forename: Magda
authors.initials: M
authors.lastname: Mărăcine
authors.forename: Corina
authors.initials: C
authors.lastname: Muscurel
authors.forename: Liliana
authors.initials: L
authors.lastname: Gârneată
authors.forename: Carmen
authors.initials: C
authors.lastname: Bărbulescu
mesh_terms: D000328:Adult; D000368:Aged; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress; D011994:Recombinant Proteins; D006435:Renal Dialysis; D013482:Superoxide Dismutase / Q000378:metabolism; D017392:Thiobarbituric Acid Reactive Substances / Q000032:analysis
chemical_list: D011994:Recombinant Proteins; D017392:Thiobarbituric Acid Reactive Substances; D004921:Erythropoietin; D013482:Superoxide Dismutase